# the Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration

> **NCT05126446** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Lifetech Scientific (Shenzhen) Co., Ltd.** · enrollment: 120 (estimated)

## Conditions studied

- Aortic Dissection

## Interventions

- **DEVICE:** the Aorta Arch Stent Graft System combined with the Endovascular Needle System

## Key facts

- **NCT ID:** NCT05126446
- **Lead sponsor:** Lifetech Scientific (Shenzhen) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-07-25
- **Primary completion:** 2027-10-30
- **Final completion:** 2028-03-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05126446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05126446, "the Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05126446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*